DO
VRTX icon

denkapparat Operations’s Vertex Pharmaceuticals VRTX Stock Holding History

denkapparat Operations’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Hold
766
– – 0.12% 300
2026
Q1 		$342K Hold
766
– – 0.14% 254
2025
Q4 		$347K Hold
766
– – 0.19% 212
2025
Q3 		$300K Hold
766
– – 0.19% 202
2025
Q2 		$341K Sell
766
-460
-38% -$212K 0.27% 156
2025
Q1 		$594K Buy
1,226
+234
+24% +$109K 0.63% 48
2024
Q4 		$399K Buy
+992
New +$460K 0.59% 57

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

denkapparat Operations's VRTX Position: Q2 2026 in Review

denkapparat Operations held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 766 shares worth $380K. The position accounts for 0.12% of the portfolio, ranked #300.

denkapparat Operations first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $594K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • denkapparat Operations held 766 shares of Vertex Pharmaceuticals worth $380K as of Q2 2026.
  • denkapparat Operations left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.12% of denkapparat Operations's portfolio in Q2 2026, its #300 holding.
  • denkapparat Operations first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • denkapparat Operations's Vertex Pharmaceuticals position peaked at $594K in Q1 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.